COMPARISON OF THE ACTIVITY AND PLASMA-LEVELS OF OXPRENOLOL, SLOW RELEASE OXPRENOLOL, LONG-ACTING PROPRANOLOL AND SOTALOL

被引:24
作者
LEAHEY, WJ [1 ]
NEILL, JD [1 ]
VARMA, MPS [1 ]
SHANKS, RG [1 ]
机构
[1] QUEENS UNIV BELFAST,DEPT THERAPEUT & PHARMACOL,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND
关键词
D O I
10.1007/BF00570158
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:419 / 424
页数:6
相关论文
共 13 条
[2]   OBSERVATIONS ON EFFICACY AND PHARMACOKINETICS OF SOTALOL AFTER ORAL-ADMINISTRATION [J].
BROWN, HC ;
CARRUTHERS, SG ;
KELLY, JG ;
MCDEVITT, DG ;
SHANKS, RG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 9 (5-6) :367-372
[3]   BIOAVAILABILITY OF CONVENTIONAL AND SLOW-RELEASE OXPRENOLOL IN FASTED AND NON-FASTED INDIVIDUALS [J].
DAWES, CP ;
KENDALL, MJ ;
WELLING, PG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (03) :299-302
[4]   SIMPLIFIED METHOD FOR DETERMINATION OF OXPRENOLOL AND OTHER BETA-RECEPTOR BLOCKING-AGENTS IN BIOLOGICAL-FLUIDS BY GAS-LIQUID-CHROMATOGRAPHY [J].
DEGEN, PH ;
RIESS, W .
JOURNAL OF CHROMATOGRAPHY, 1976, 121 (01) :72-75
[5]   SEPARATION AND SPECTROFLUOROMETRIC ASSAY OF BETA-ADRENERGIC BLOCKER SOTALOL FROM BLOOD AND URINE [J].
GARRETT, ER ;
SCHNELLE, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (06) :833-&
[6]  
Gatley M S, 1968, J R Coll Gen Pract, V16, P39
[7]  
LEAHEY WH, BRIT J CLIN PHARMACO
[8]  
MASON WD, 1976, CLIN PHARMACOL THER, V20, P401
[9]   PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH LONG-ACTING PROPRANOLOL [J].
MCAINSH, J ;
BABER, NS ;
SMITH, R ;
YOUNG, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (02) :115-121
[10]  
MCDEVITT DG, 1977, CLIN PHARMACOL THER, V21, P556